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Abstract
Expectations about future health and longevity are important determinants of individuals’ 
decisions to invest in physical and human capital. Few population-level studies have measured 
subjective expectations and examined how they are affected by scale-up of antiretroviral therapy 
(ART). We assessed these expectations in communities receiving annual HIV testing and universal 
ART. Longitudinal data on expectations were collected at baseline and one year later in 16 
intervention communities participating in the Sustainable East Africa Research in Community 
Health (SEARCH) trial of the test and treat strategy in Kenya and Uganda (NCT01864603). A 
random sample of households with and without an HIV-positive adult was selected after baseline 
HIV testing. Individuals’ expectations about survival to 50, 60, 70, and 80 years of age, as well as 
future health status and economic well-being, were measured using a Likert scale. Primary 
outcomes were binary variables indicating participants who reported being very likely or almost 
certain to survive to advanced ages. Logistic regression analyses were used to examine trends in 
expectations as well as associations with HIV status and viral load for HIV-positive individuals. 
Data were obtained from 3126 adults at baseline and 3977 adults in year 1, with 2926 adults 
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participating in both waves. HIV-negative adults were more likely to have favorable expectations 
about survival to 60 years than HIV-positive adults with detectable viral load (adjusted odds ratio 
[AOR] 1.87, 95% CI 1.53–2.30), as were HIV-positive adults with undetectable viral load (AOR 
1.41, 95% CI 1.13–1.77). Favorable expectations about survival to 60 years were more likely for 
all groups in year 1 compared to baseline (AOR 1.53, 95% CI 1.31–1.77). These findings are 
consistent with the hypothesis that universal ART leads to improved population-level expectations 
about future health and well-being. Future research from the SEARCH trial will help determine 
whether these changes are causally driven by the provision of universal ART.
Keywords
Antiretroviral therapy; test and treat; health expectations; subjective life expectancy
Background
Life expectancy has long been hypothesized as an important determinant of individuals’ 
decisions to invest in physical and human capital (Becker, 1964; Ben-Porath, 1967) and this 
premise of economic theory has played a central role in the study of economic development. 
Several recent studies have empirically documented a link between changes in life 
expectancy and human capital investment, with one study showing that during the early 
years of the HIV/AIDS epidemic when life expectancy declined considerably, households 
reduced their investments in schooling (Fortson, 2011; Jayachandran & Lleras-Muney, 2009; 
Oster, Shoulson, & Dorsey, 2013). Moreover, because it strengthens the incentives to invest 
in human capital, life expectancy has also been recognized as having a causal effect on 
economic growth at the macroeconomic level (Kalemli-Ozcan, 2002; Soares, 2005).
Given the potential importance of life expectancy in decision-making, there is growing 
recognition of the value of measuring individuals’ subjective expectations about future 
health and studying factors that influence these expectations. In the US and other developed 
countries, elicitation of individuals’ expectations about survival to advanced ages and about 
major life events has become fairly common. For example, the Health and Retirement 
Survey has included such measures (Hurd & McGarry, 1995, 2002) and several studies have 
shown that eliciting individuals’ expectations is not only feasible but also useful for 
understanding important aspects of individuals’ decisions (Delavande & Rohwedder, 2011). 
In developing countries, however, very few population-level studies have elicited 
individuals’ expectations about longevity (Delavande, Gine, & McKenzie, 2011).
Particularly in sub-Saharan Africa (SSA), which saw dramatic declines in life expectancy 
after the onset of HIV/AIDS epidemic followed by large reductions in adult mortality as 
HIV treatment with antiretroviral therapy (ART) was scaled-up in the past decade 
(UNAIDS, 2015), there have been strikingly few studies examining associations between 
HIV/AIDS and individuals’ subjective expectations about life expectancy. One study in 
Malawi has measured individuals’ survival expectations and examined its association with 
key socio-economic characteristics as well HIV-related risk behaviors (Delavande & Kohler, 
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2009), but no studies have examined how individuals may be updating their expectations as 
ART scale-up occurs and bolder “treatment as prevention” strategies are implemented.
We assessed cross-sectional patterns and trends in individuals’ subjective expectations about 
survival, health, and economic conditions in rural Kenyan and Ugandan communities that 
began receiving annual HIV testing and universal ART.
Methods
Data were collected in two waves, at baseline and year 1, in 16 intervention communities 
participating in the ongoing Sustainable East Africa Research in Community Health 
(SEARCH) HIV test and treat cluster randomized controlled trial (NCT01864603). The 
SEARCH trial consists of 32 communities (20 in eastern and southwestern Uganda and 12 
in western Kenya), which were selected from 54 candidate communities that met initial 
eligibility criteria of a rural community, had a population of about 10,000 individuals, and 
contained an HIV clinic. Sixteen matched pairs of communities were selected on the basis of 
region, population density, occupational mix, access to transport routes, and number of 
trading centers (Balzer, Petersen, van der Laan, & SEARCH Consortium, 2015).
Procedures used to enumerate study communities and implement a hybrid mobile HIV 
testing approach in each community at baseline have recently been described elsewhere 
(Chamie et al., 2016). In brief, at baseline a door-to-door census was first conducted in each 
community. This was followed by 2 week multiple-disease community health campaigns 
(CHCs) that included HIV testing, counseling, and referral to care if HIV infected. Non-HIV 
services designed to improve community health were also provided, and these included 
hypertension and diabetes screening, malaria rapid diagnostic testing for participants with 
fever, male condom distribution, referral for medical male circumcision, family planning and 
cervical cancer screening, and vitamin A and albendazole treatment for young children. The 
CHCs were held at central locations in communities. Individuals aged ≥15 years who did not 
participate in the CHCs were approached for home-based testing (HBT) within 1–6 months 
after the CHC. For HIV-positive individuals, HIV-1 viral load measurements were performed 
by reference testing laboratories in Uganda, Kenya and the United States using commercial 
real-time PCR assays following the manufacturer’s instructions. This hybrid testing 
approach achieved a high level of HIV testing coverage in the population at baseline 
(Chamie et al., 2016) and was repeated one year later in the sixteen SEARCH intervention 
communities.
In SEARCH intervention communities, HIV-positive individuals are rapidly initiated on 
ART independent of CD4 cell count. ART is delivered in a streamlined, patient-centered, 
approach that includes appointment reminders, quarterly visits, reduced waiting times at 
clinics, and viral load results counseling wherein patients receive their viral load results and 
counseling to understand the anticipated benefits of viral suppression and consequences of 
detectable viral loads. The control communities follow country guidelines for ART initiation 
and delivery.
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Immediately following the CHCs and in parallel with HBT, a random sample of households 
with and without an HIV-positive adult were selected for structured household surveys. One 
HIV-positive adult (i.e. index person) was selected in the households that contained one or 
more HIV-positive adults, and one HIV-negative adult (i.e. index person) was selected 
randomly in the households with no HIV-positive adults. In each community, we aimed to 
conduct surveys with 100 households that included an HIV-positive adult and 100 
households that did not include an HIV-positive adult. The surveys assessed socio-economic 
conditions of households and consisted of several modules that obtained information on 
demographic characteristics, employment and income of household members aged ≥12 
years, ownership of assets, health care utilization, and education of household members aged 
6–25 years. These surveys were adapted from Living Standards Measurement Surveys 
(Grosh & Glewwe, 2000) administered in numerous developing countries. Surveys were 
administered by trained interviewers who visited the randomly sampled households. 
Information collected in the surveys was linked at the individual level to information on HIV 
status (and for HIV-positive adults, to HIV-1 viral load) that was obtained during CHCs and 
HBT. Household surveys were repeated one year later with the same households that 
participated in the baseline surveys.
Expectations measures
In the household surveys, individuals’ expectations about their likelihood of survival to 50, 
60, 70, and 80 years of age were measured using a 5-point Likert scale. Expectations about 
survival to each of the four ages were only elicited if the individual was younger than the 
corresponding target age. Individuals’ expectations about their own health in 1 year and 3 
years were also elicited using a 5-point Likert scale, as were their expectations about the 
standard of living of their community in 1 year and the financial well-being of their own 
household in 3 years. At baseline, questions about expectations were administered to only 
one randomly-selected adult in each household whereas at follow-up year 1, these questions 
were administered to all adult household members who were present at the time of the 
survey.
Statistical analyses
Analyses of baseline and follow-up data were limited to SEARCH intervention communities 
and did not include comparisons to control communities because the SEARCH trial is 
ongoing. For each of the advanced ages for which we elicited expectations, participants’ 
responses were classified as binary variables that indicated whether they felt it was “very 
likely” or “almost certain” they would survive the corresponding age, or if instead they 
responded with “almost impossible”, “not very likely”, or “maybe”. Similarly, for 
expectations about future health status and economic well-being, participants’ responses 
were classified as binary variables that indicated whether they felt it was “very likely” or 
“almost certain”. Logistic regression models were used to examine the association between 
each of the binary expectation measures and key exposure variables and to estimate time 
trends. The main exposure variable of interest was a categorical variable indicating whether 
an individual was HIV-negative, HIV-positive with HIV-1 viral load <500 copies/μL 
(undetectable viral load), or HIV-positive with HIV-1 viral load ≥500 copies/μL (detectable 
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viral load). Viral load was included in the exposure measure to reflect successful ART use. 
HIV-positive individuals with detectable viral load served as the reference group.
In analyses that pooled the baseline and follow-up year 1 data, time trends were estimated 
using a binary variable that indicated whether the outcome was being measured in follow-up 
year 1. The analyses also controlled for several individual characteristics including gender, 
age (defined in four categories), highest level of education completed (defined in three 
categories: no education, primary level, secondary level, or greater), marital status, and 
included community and interviewer fixed effects. Models with individual fixed effects were 
also estimated to examine the association between the main outcomes and viral load using 
variation over time in HIV-positive individuals’ viral load.
The Makerere University School of Medicine Research and Ethics Committee, the Ugandan 
National Council for Science and Technology, the Kenya Medical Research Institute Ethical 
Review Committee, and the University of California San Francisco Committee on Human 
Research approved the study. All participants provided verbal informed consent in their 
preferred language with fingerprint confirmation of consent.
Results
Household surveys that obtained information on individuals’ subjective expectations were 
conducted at study baseline, between July 2013 and August 2014, with 3118 households in 
the 16 intervention communities. A total of 3126 adults responded to questions on subjective 
expectations at baseline. In follow-up year 1, 2973 households were revisited between 
October 2014 and September 2015 and information on subjective expectations was obtained 
from 3977 adults. Our analytic sample was restricted to subjects whose HIV status and 
HIV-1 viral load were known and who were between the ages of 18–80 years at time of 
survey (2676 individuals in 2670 households at baseline and 3410 individuals in 2695 
households at follow-up year 1). For analyses of expectations to survive to 50, 60, 70, and 80 
years, respectively, individuals who were younger than the corresponding target age were 
excluded.
Table 1 summarizes key demographic and socioeconomic characteristics of study 
participants in the analytic sample. Approximately 64% of all respondents were female. 
Approximately 70% of respondents were married, and at baseline, about 20% of respondents 
were between 18 and 25 years of age and about 70% were ≤45 years of age. At baseline and 
follow-up year 1, 63.8% and 64.8% of respondents were HIV-negative, respectively.
Participants’ expectations at baseline and follow-up year 1 about survival to advanced ages, 
as well as future health and financial well-being, are summarized in Table 2 and Figure 1. As 
the target age increased, the proportion of participants who reported being very likely or 
almost certain to survive until that age declined monotonically. For example, among all 
participants who responded at baseline, 53% of participants reported being very likely or 
almost certain to survive until 50 years whereas only 40.9%, 28.1%, and 20.7% of 
participants reported being very likely or almost certain to survive until 60, 70, and 80 years, 
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respectively. A similar pattern in survival expectations was observed in follow-up year 1 
data.
Survival expectations of participants changed considerably between baseline and follow-up 
(Figure 1). For each of the advanced ages that were discussed in the expectations surveys, a 
higher proportion of participants reported being very likely or almost certain to survive until 
that age at follow-up year 1 than at baseline. Similar shifts were observed in the expectations 
of one’s health status in 1 and 3 years from the time of the survey (not reported).
Measures of current health such as HIV status and viral load as well as expectations of 
future health were strongly associated with participants’ reported survival expectations at 
baseline (Table 3). Compared to HIV-positive adults with a detectable viral load, adults who 
were HIV-positive and had an undetectable viral load were significantly more likely to report 
being very likely or almost certain to survive to 50 years (unadjusted odds ratio [OR] 1.64, 
95% CI 1.26–2.14). HIV-negative adults also had significantly higher expectations than HIV-
positive adults with detectable viral load (OR 1.56, 95% CI 1.25–1.94). A similar pattern 
was observed for expectations of survival to ages of 60 and 70 years, although for these ages 
HIV-negative adults had slightly higher expectations than HIV-positive adults with 
undetectable viral load. For survival to age 80 years, there was no significant difference in 
expectations between HIV-positive adults with detectable and undetectable viral load (OR 
1.28, 95% CI 0.91–1.79), but HIV-negative adults were significantly more likely to report 
being very likely or almost certain of survival than HIV-negative adults with detectable viral 
load (OR 1.66, 95% CI 1.26–2.19). In all of these analyses, post-estimation hypotheses 
testing that compared regression coefficients indicated there were no significant differences 
in expectations between HIV-negative persons and HIV-positive persons with undetectable 
viral load.
Further validation of expectations measures was obtained by comparing participants’ 
expectations about their future health with their survival expectations (Table 3). Relative to 
those who expected to be in worse or similar health in 3 years, those who expected to be in 
somewhat better or much better health were significantly more likely to report being very 
likely or almost certain to survive to each of the four target ages (for survival to 60 years, 
OR 1.81, 95% CI 1.52–2.15). In addition, those who expected to be in much better health 
generally had better survival expectations than those who expected to be in somewhat better 
health.
In models that combined data from baseline and follow-up year 1 and included controls for 
important individual- and household-level characteristics as well as community fixed effects 
and interviewer fixed effects (Table 4), the associations with HIV status and viral load 
largely remained evident. Survival expectations were also associated with gender and 
education. Women had a lower likelihood of reporting being very likely or almost certain to 
survive to the advanced ages, and individuals with secondary or more education had more 
favorable survival expectations. In general, older individuals who were closer to the ages 
specified in elicitations of survival expectations had higher odds of reporting being likely to 
survive to those ages, although these individuals were also significantly more likely to 
expect their health to deteriorate in the next year 1 year and 3 years.
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Expectations about survival to advanced ages, health status, and financial well-being of 
one’s household and community became significantly more favorable over time. For 
example, participants were more likely to report being very likely or almost certain to 
survive until 60 years in year 1 than at baseline (adjusted odds ratio (AOR) 1.53, 95% CI 
1.31–1.77). Similar time trends were found in expectations about health in 1 year (AOR 
2.12, 95% CI 1.82–2.47) and 3 years (AOR 1.63, 95% CI 1.40–1.89). Between baseline and 
follow-up year 1, participants in SEARCH intervention communities also developed more 
favorable expectations about the future standard of living of their own community (for 
reporting that the standard of living would be somewhat or much better, AOR 1.49, 95% CI 
1.29–1.71). A similar time trend was observed in expectations the economic well-being of 
their own household would be somewhat or much better (AOR 1.41, 95% CI 1.23–1.61). 
These time trends in expectations were also found in models that excluded all covariates and 
only included measures of HIV status and viral load (Appendix Table 1A), as well as models 
with individual fixed effects that used data from only those individuals appearing in both 
waves of data collection and controlled for time-invariant individual characteristics 
(Appendix Table 2).
Discussion
This study assesses patterns in individuals’ health, survival, and economic expectations in a 
large sample of adults in Kenya and Uganda that includes sizable numbers of HIV-positive 
and HIV-negative adults. Individuals’ subjective assessments of their likelihood of surviving 
to advanced ages were largely correlated with objective measures of health status, including 
HIV status and an indicator of whether those who were HIV-positive were virally 
suppressed. The measures of subjective life expectancy were validated by comparisons to 
individuals’ expectations about their future health. In addition, individuals’ expectations 
about their future health, life expectancy, and economic circumstances became more 
favorable over time. This positive trend was observed among both HIV-positive and HIV-
negative adults in the SEARCH intervention communities.
A key finding in this study was that HIV-positive individuals with an undetectable viral load 
had relatively similar expectations about survival to advanced ages as HIV-negative adults. 
Moreover, compared to HIV-positive individuals with a detectable viral load, expectations to 
survive to advanced ages were significantly higher among both HIV-negative individuals and 
HIV-positive individuals with an undetectable viral load. These findings are consistent with 
the possibility that HIV-positive individuals who realize the well-documented individual 
health benefits of ART initiation (Cohen et al., 2011) and information received in viral load 
counseling tend to update their expectations about future health, a finding that has not been 
reported previously.
Other findings in this study provide support for the validity of the expectations measures and 
their value in evaluations of health interventions, including universal test and treat 
interventions. Survival expectations elicited from individuals had an education gradient that 
is consistent with life expectancies among individuals of different education levels, and 
expectations of survival declined as the target age increased. These and other patterns in 
individuals’ subjective expectations were comparable to those reported in a few other 
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population-based studies conducted in SSA. As observed in Malawi (Delavande & Kohler, 
2009) and in high-income countries, despite having greater life expectancies than men, 
women reported a lower subjective expectation of survival to advanced ages than men 
(Delavande & Rohwedder, 2011; Hurd & McGarry, 1995).
A striking finding is that in the SEARCH trial communities, individuals’ subjective 
expectations about their likelihood of survival to advanced ages increased significantly over 
a one year period. Explanations for the sizable, positive trend in expectations include the 
multi-disease screening and services provided at CHCs, which enabled many individuals to 
learn whether they had HIV (Chamie et al., 2016) and also receive prompt referral to care, 
particularly ART irrespective of CD4 count for those who were HIV-positive. Actual 
improvements in the health of individuals and others in their networks could have also 
bolstered optimism about future health and survival to advanced ages. Explanations related 
to ART expansion would be consistent with several studies showing that ART expansion has 
led to substantial reductions in mortality and gains in life expectancy (Bendavid, Holmes, 
Bhattacharya, & Miller, 2012; Bor, Herbst, Newell, & Barnighausen, 2013) as well as 
improvements in economic conditions (Bor, Tanser, Newell, & Barnighausen, 2012; 
Thirumurthy, Zivin, & Goldstein, 2008; Wagner, Barofsky, & Sood, 2015). However, to our 
knowledge this is the first study to examine trends in individuals’ subjective expectations 
about health, survival, and economic conditions following expanded ART provision. Despite 
these potential explanations, it is also possible that other unrelated factors may have 
influenced these measures. Future research that utilizes additional longitudinal data and 
compares SEARCH intervention and control communities can be useful for better 
understanding these trends.
There are several limitations of this study that should be noted. Because trends in the 
SEARCH intervention communities were not compared to those in control communities, 
where CHCs did not occur by design in year 1, it is not possible to assess whether the 
observed changes in expectations were due to the implementation of universal test and treat 
interventions. Instead, these data are useful for studying factors associated with individuals’ 
expectations and for generating hypotheses about the likely role of ART scale-up in 
influencing these expectations. Because our study measured expectations using a Likert 
scale instead of a probabilistic scale, as some other studies have done (Delavande et al., 
2011; Delavande & Kohler, 2009), our data cannot be used to compute specific life 
expectancies held by individuals. The methodology we used can make interpersonal 
comparisons more challenging, but this can be overcome by reliance on longitudinal data 
instead. Moreover, probabilistic expectations measures have other drawbacks, as individuals 
have been shown to substantially overestimate their mortality risk (Delavande & Kohler, 
2009). Finally, the results presented here do not address whether individuals’ expectations 
influence their forward-looking behaviors, which is a question that will be examined in our 
future work.
As major investments in improving population health are undertaken, measuring subjective 
expectations of individuals can be useful for assessing whether objective improvements in 
health status are accompanied by changes in individuals’ expectations. The findings reported 
here are largely supportive of the hypothesis that bold efforts to eliminate new HIV 
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infections through a “test and treat” strategy can contribute to positive changes at the 
population level in individuals’ expectations about their future health and well-being. 
However, definitive conclusions can only be drawn after making comparisons to SEARCH 
trial communities that have received the standard of care, including ART according to 
country guidelines.
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Appendix
Appendix Table 1A
Unadjusted logistic regression results using pooled data from baseline and follow-up.
50 years
OR [95% 
CI]
60 years
OR [95% 
CI]
70 years
OR [95% 
CI]
80 years
OR [95% 
CI]
Health in 
1 year
OR [95% 
CI]
Health in 
3 years
OR [95% 
CI]
Standard 
of living in 
this 
community 
in 1 year
OR [95% 
CI]
Household 
financial 
well-being 
in 3 years
OR [95% 
CI]
Follow-up year 1 
indicator variable
1.34***
[1.18–1.51]
1.45***
[1.30–1.62]
1.40***
[1.25–1.57]
1.37***
[1.21–1.55]
1.44***
[1.29–1.60]
1.38***
[1.24–1.54]
1.37***
[1.24–1.52]
1.32***
[1.20–1.46]
HIV status and 
viral load
 Ref: HIV+, 
detectable viral 
load
Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref.
 HIV+, 
undetectable viral 
load
1.34**
[1.10–1.65]
1.50***
[1.22–1.83]
1.40**
[1.11–1.76]
1.17
[0.91–1.50]
1.02
[0.84–1.24]
1.03
[0.85–1.25]
0.93
[0.78–1.12]
0.91
[0.75–1.09]
 HIV status 1.70***
[1.41–2.05]
1.94***
[1.62–2.33]
1.92***
[1.55–2.37]
1.61***
[1.28–2.03]
1.01
[0.85–1.20]
1.09
[0.91–1.30]
1.14
[0.96–1.35]
1.10
[0.92–1.30]
Observations 4433 5289 5438 5516 5889 6086 6086 6086
Number of clusters 3108 3670 3854 3944 4105 4177 4177 4177
Notes: OR, odds ratio; 95% CI, 95% confidence interval. Logistic regression models included an indicator variable for 
follow-up year 1 and controls for HIV status and HIV-1 viral load. For each of the target ages of 50, 60, 70, and 80 years, 
the sample was limited to participants who were younger than the target age. Ninety-five percentage confidence intervals 
calculated using robust standard errors clustered at the individual level are reported in brackets.
**p < .01.
***p < .001.
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Appendix Table 2
Linear probability models with individual fixed effects.
Very likely or almost certain to survive to Very likely or almost certain to have better
50 years 60 years 70 years 80 years
Health in 1 
year
Health in 3 
years
Standard of 
living in this 
community 
in 1 year
Household 
financial 
well-being 
in 3 years
Coef.
[95% CI]
Coef.
[95% CI]
Coef.
[95% CI]
Coef.
[95% CI]
Coef.
[95% CI]
Coef.
[95% CI]
Coef.
[95% CI]
Coef.
[95% CI]
Follow-up year 1 
indicator variable
0.19**
[0.06–0.31]
0.34***
[0.22–0.46]
0.24***
[0.11–0.37]
0.21**
[0.07–0.36]
0.30***
[0.17–0.43]
0.29***
[0.15–0.43]
0.27***
[0.13–0.41]
0.20**
[0.07–0.34]
HIV status and viral 
load
(Ref: HIV+, detectable 
viral load)
Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref.
HIV+, undetectable 
viral load* Year 1
−0.16
[−0.34–0.01]
−0.19*
[−0.35–−0.03]
−0.13
[−0.30–0.05]
−0.07
[−0.27–0.12]
−0.11
[−0.29–0.07]
−0.12
[−0.30–0.07]
−0.27**
[−0.46–−0.08]
−0.06
[−0.24–0.12]
HIV-status* Year 1 −0.03
[−0.18–0.12]
−0.13
[−0.27–0.00]
−0.02
[−0.17–0.13]
−0.06
[−0.22–0.11]
−0.12
[−0.27–0.03]
−0.10
[−0.26–0.06]
−0.01
[−0.17–0.15]
−0.06
[−0.21–0.09]
Number of observations 2,928 3,550 3,436 3,406 3,902 4,180 4,180 4,180
Number of individuals 1,464 1,775 1,718 1,703 1,951 2,090 2,090 2,090
Abbreviations: Coef., coefficient; 95% CI, 95% confidence interval. Linear regression models included indicator variable 
for follow-up year 1, indicator variables for baseline HIV/viral load status, and an interaction between these variables and 
year 1. Sample was restricted to participants who answered questions in each wave. P-values notation:
***p < 0.001,
**p <0.01.
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Figure 1. 
Trends in survival at baseline and follow-up year 1. Notes: Each bar represents participants’ 
subjective expectations to survive to age 50, 60, 70, and 80 using a 5-point Likert scale. 
Responses are presented separately for baseline and follow-up year 1. Expectations about 
survival to each of the target ages of 50, 60, 70, and 80 years were elicited from participants 
aged below the corresponding target age.
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Table 1
Descriptive characteristics of study participants in SEARCH intervention communities.
Baseline No. (%) Follow-up year 1 No. (%) p-Value
No. individuals 2676 3410
No. households 2670 2695
HIV status
 HIV+, detectable viral load   526 (19.7)   164 (4.8) <0.001
 HIV+, undetectable viral load   535 (20.0) 1,084 (31.8) <0.001
 HIV-status 1615 (60.4) 2162 (63.4)   0.009
Female 1706 (63.8) 2209 (64.8)   0.723
Age categories
 18–25 years old   530 (19.8)   561 (16.5)   0.151
 26–35 years old   730 (27.3)   859 (25.2)   0.043
 36–45 years old   602 (22.5)   808 (23.7)   0.765
 46–80 years old   814 (30.4) 1182 (34.7)   0.004
Education level
 No education   439 (16.4)   503 (14.8)   0.068
 Primary education 1669 (62.4) 2201 (64.6)   0.121
 Secondary or more education   567 (21.2)   703 (20.6)   0.839
Married/cohabiting 1828 (68.3) 2430 (71.3)   0.117
Wealth index
 Least wealth   576 (21.6)   655 (19.2)   0.012
 Less wealth   549 (20.6)   667 (19.6)   0.260
 Middle wealth   512 (19.2)   658 (19.3)   0.876
 More wealth   520 (19.5)   693 (20.3)   0.317
 Most wealth   512 (19.2)   737 (21.6)   0.006
Region
 Southwest Uganda   837 (31.3) 1064 (31.2)   0.744
 Eastern Uganda   818 (30.6) 1100 (32.3)   0.744
 Kenya 1021 (38.2) 1246 (36.5)   0.532
Notes: p-Values based on chi-squared tests comparing characteristics of participants at baseline and follow-up. Wealth quintiles are based on a 
wealth index created using principal components analysis of ownership of 47 items. Characteristics reported are for participants aged 18–80 years, 
with HIV status and HIV-1 viral load information.
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Table 3
Bivariate logistic regression results at baseline
Very likely or almost certain to survive to
50 years
OR [95% CI]
60 years
OR [95% CI]
70 years
OR [95% CI]
80years
OR [95% CI]
HIV status and viral load
 Ref: HIV+, detectable viral load Ref. Ref. Ref. Ref.
  HIV+, undetectable viral load 1.64***
[1.26–2.14]
1.59***
[1.22–2.06]
1.48*
[1.10–2.00]
1.28
[0.91–1.79]
  HIV-status 1.56***
[1.25–1.94]
1.89***
[1.52–2.35]
1.92***
[1.49–2.47]
1.66***
[1.26–2.19]
 Observations 2000 2352 2415 2477
Expected future health
 Better or much better health in 1 year 1.90***
[1.58–2.29]
1.80***
[1.51–2.13]
1.63***
[1.35–1.96]
1.63***
[1.32–2.00]
 Observations 1931 2270 2339 2403
 Much better health in 1 year 2.92***
[2.19–3.88]
2.34***
[1.84–2.98]
1.84***
[1.44–2.35]
1.79***
[1.38–2.33]
 Observations 1931 2270 2339 2403
 Better or much better health in 3 years 1.91***
[1.58–2.29]
1.81***
[1.52–2.15]
1.50***
[1.24–1.82]
1.54***
[1.25–1.89]
 Observations 2000 2352 2415 2477
 Much better health in 3 years 2.77***
[2.20–3.48]
2.06***
[1.69–2.51]
1.56***
[1.27–1.92]
1.50***
[1.20–1.88]
 Observations 2000 2352 2415 2477
Notes: OR, odds ratio; 95% CI, 95% confidence interval. Logistic regression model was used to separately examine the association between the 
binary dependent variables and each of the five independent variables: (1) HIV status and HIV-1 viral load; (2) better or much better health in 1 
year; (3) much better health in 1 year; (4) better or much better health in 3 years; (5) much better health in 3 years in separate logistic regression 
models. For each of the target ages of 50, 60, 70, and 80 years, the sample was limited to participants who were younger than the target age. 95% 
confidence intervals calculated using robust standard errors clustered at the individual level are reported in brackets.
*p < .05.
***p < .001.
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